SANTA ANA, CALIFORNIA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem cell and exosome therapies, today ...
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any ...
(RTTNews) - PrimeGen US, Inc., on Wednesday, announced it has entered into a definitive business combination agreement with DT Cloud Star Acquisition Corporation (DTSQ), a publicly traded special ...
PrimeGen US and DT Cloud Star Acquisition have entered a definitive business combination agreement at an implied equity value of around $1.5bn. The agreement aims to advance PrimeGen US’s stem cell ...
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the public markets. The California biotech, which is working on preclinical stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results